Loading...
Loading...
By Sofía Garduño - Thu, 04/18/2024 - 09:35
Mexico's pharmaceutical sector could benefit from producing APIs, but policy gaps may impede growth, says Philippe Fournet-Fayard, CEO of Eolis Latam.
Featured content
Thu, 04/11/2024 - 15:25
Current regulation in Mexico hinders the full development of healthcare markets, including cannabis and AI, says BPF’s Jaime Castro.
https://mexicobusiness.news/tag/nearshoring
More Health
By Guillaume Corpart - Wed, 03/27/2024 - 10:00
In 2024, transformative changes are expected in the global healthcare industry, driven by tech and changes in public health, writes Guillaume Copart
By Sofía Garduño - Fri, 06/30/2023 - 15:26
Quality is not a burden but an opportunity to contribute to the well-being of individuals and countries, explains PQE Group's Gilda D'Incerti.
By Héctor Orellana - Fri, 06/02/2023 - 11:00
The medical device industry in Mexico has gained greater relevance and is experiencing a moment of opportunity, writes Héctor Orellana.
By Sofía Garduño - Fri, 03/24/2023 - 13:23
Data analysis is essential to control costs while improving medical outcomes, says Javier Pinzón, Director General of doHealth.
By Sandra Sánchez-Oldenhage - Thu, 03/09/2023 - 08:45
Mexico can be a formidable alternative to China for pharma manufacturers — if it can manage its drawbacks, writes Sandra Sánchez-Oldenhage.
By Rafael Gual - Thu, 07/14/2022 - 10:00
Rafael Gual looks at the pharmaceutical industry in Mexico, discussing its relevance from both a social and economic viewpoint.
By Miriam Bello - Fri, 08/13/2021 - 15:38
COVID-19 has sparked opportunities for already promising sectors of the Mexican economy.
